These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3880414)

  • 1. Prognosis of occlusive disease of the circle of Willis (moyamoya disease) in children.
    Kurokawa T; Tomita S; Ueda K; Narazaki O; Hanai T; Hasuo K; Matsushima T; Kitamura K
    Pediatr Neurol; 1985; 1(5):274-7. PubMed ID: 3880414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of moyamoya disease with STA-MCA anastomosis.
    Karasawa J; Kikuchi H; Furuse S; Kawamura J; Sakaki T
    J Neurosurg; 1978 Nov; 49(5):679-88. PubMed ID: 712390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and cerebral angiographic evolutions of idiopathic progressive occlusive disease of the circle of Willis ("moyamoya" disease) in children.
    Fukuyama Y; Umezu R
    Brain Dev; 1985; 7(1):21-37. PubMed ID: 4003707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revascularization for moyamoya disease: five-year follow-up.
    Eller TW; Pasternak JF
    Surg Neurol; 1987 Dec; 28(6):463-7. PubMed ID: 3686328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revascularization surgery for moyamoya disease.
    Nakagawa Y; Abe H; Sawamura Y; Kamiyama H; Gotoh S; Kashiwaba T
    Neurol Res; 1988 Mar; 10(1):32-9. PubMed ID: 2899853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion.
    Hayashi T; Shirane R; Fujimura M; Tominaga T
    J Neurosurg Pediatr; 2010 Jul; 6(1):73-81. PubMed ID: 20593991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relevance of hemodynamic factors to perioperative ischemic complications in childhood moyamoya disease.
    Iwama T; Hashimoto N; Yonekawa Y
    Neurosurgery; 1996 Jun; 38(6):1120-5; discussion 1125-6. PubMed ID: 8727141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pediatric moyamoya patients. Age at the time of surgery as a factor in the postoperative clinical course].
    Matsushima Y; Takasato Y; Yamaguchi T; Tabata H; Aoyagi M; Kitoh K; Inaba Y
    Neurol Med Chir (Tokyo); 1987 Sep; 27(9):856-60. PubMed ID: 2451174
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk Factors Associated with Neurologic Deterioration After Combined Direct and Indirect Revascularization in Patients with Moyamoya Disease on the East Coast of China.
    Zhai X; Mao L; Wang H; Zhang X; Hang C; Wu W; Jia Y; Liu L
    World Neurosurg; 2018 Oct; 118():e92-e98. PubMed ID: 29945005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of Moyamoya disease by superficial temporal-middle cerebral artery (STA-MCA) anastomosis.
    Erickson DL; Koivukangas J
    Ann Clin Res; 1986; 18 Suppl 47():21-4. PubMed ID: 3813465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic subdural hematoma developing after EMS for moyamoya disease].
    Sonobe M; Takahashi S; Kubota Y; Shirane R
    No Shinkei Geka; 1982 Aug; 10(8):857-9. PubMed ID: 7133306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis.
    Scott RM; Smith JL; Robertson RL; Madsen JR; Soriano SG; Rockoff MA
    J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):142-9. PubMed ID: 14758941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steno-occlusive changes in the external carotid system in moyamoya disease.
    Komiyama M; Nishikawa M; Yasui T; Kitano S; Sakamoto H; Fu Y
    Acta Neurochir (Wien); 2000; 142(4):421-4. PubMed ID: 10883339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Follow-up study on the relationship between age at onset of illness and outcome in patients with moyamoya disease].
    Moritake K; Handa H; Yonekawa Y; Taki W; Okuno T
    No Shinkei Geka; 1986 Jul; 14(8):957-63. PubMed ID: 3748299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down syndrome and moyamoya: clinical presentation and surgical management.
    See AP; Ropper AE; Underberg DL; Robertson RL; Scott RM; Smith ER
    J Neurosurg Pediatr; 2015 Jul; 16(1):58-63. PubMed ID: 25837890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment.
    Kim SK; Seol HJ; Cho BK; Hwang YS; Lee DS; Wang KC
    Neurosurgery; 2004 Apr; 54(4):840-4; discussion 844-6. PubMed ID: 15046649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral blood flow in children with spontaneous occlusion of the circle of Willis (moyamoya disease): comparison with healthy children and evaluation of annual changes.
    Kuroda S; Kamiyama H; Abe H; Yamauchi T; Kohama Y; Houkin K; Mitsumori K
    Neurol Med Chir (Tokyo); 1993 Jul; 33(7):434-8. PubMed ID: 7692320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment of moyamoya disease in pediatric age.
    Caldarelli M; Di Rocco C; Gaglini P
    J Neurosurg Sci; 2001 Jun; 45(2):83-91. PubMed ID: 11533532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for neurologic deterioration after revascularization surgery in patients with moyamoya disease.
    Sakamoto T; Kawaguchi M; Kurehara K; Kitaguchi K; Furuya H; Karasawa J
    Anesth Analg; 1997 Nov; 85(5):1060-5. PubMed ID: 9356100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Moyamoya syndrome in neuroanesthesia].
    Gulden WD; Brandt M; Scherer R; Lawin P
    Anasth Intensivther Notfallmed; 1987 Feb; 22(1):33-6. PubMed ID: 3578721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.